Stem cells, exosomes, gene therapy, peptides, hyperbaric oxygen, and epigenetic reprogramming
390 articles
A new Nature Biotechnology review maps how large-scale AI foundation models are transforming biomedicine, from genomics to clinical diagnostics.
Scientists built the first in vitro menstrual cycle using organoids, uncovering WNT7A as a key driver of scarless endometrial regeneration.
Embryonic brain precursor cells grafted into adult rat striatum successfully integrate and reduce motor deficits in a Parkinson's disease model.
Allez au-delà des notions fondamentales pour comprendre les enzymes, les voies de signalisation et la communication intercellulaire qui régissent le vieillissement de votre matrice extracellulaire — et ce que les chercheurs font pour y remédier.
Next-gen CAR-T approaches skip the lab and engineer immune cells directly inside the body, potentially making cancer therapy faster and cheaper.
Découvrez le cadre invisible qui maintient votre corps ensemble — et pourquoi préserver sa santé représente l'une des frontières les plus fascinantes de la science de la longévité.
A comprehensive review reveals how biomaterials, stem cells, and 3D bioprinting are converging to restore damaged endometrial tissue and treat infertility.
Intellia's in vivo CRISPR treatment edits genes directly inside living patients and just cleared a Phase 3 trial — a world first.
Intellia Therapeutics reports a landmark Phase 3 win for CRISPR gene editing, potentially offering a one-time cure for a debilitating genetic disease.
Single-cell sequencing reveals ferroptosis drives pulpitis; thymosin α1 restores GPX4, cuts iron overload, and reduces inflammation in cells and rats.
Engineered immune cells simultaneously dissolve cardiac fibrosis and rebuild heart muscle in mice, offering a dual-action therapy for heart failure.
Scientists discover muscle cells bypass normal nuclear pores to export oversized RNA transcripts via a newly identified budding pathway.
